AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Biogliz M 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Biocore Pharmaceuticals

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Biogliz M 2mg/500mg Tablet

Glyconia Duo 2mg/500mg tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Glyconia Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication is only one component of a comprehensive diabetes management plan that includes a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are critical for diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential to mitigate this risk. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating women should seek medical counsel prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Uses of Biogliz M 2mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Biogliz M 2mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Biogliz M 2mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Biogliz M 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Biogliz M 2mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or breaking it. Biogliz M 2mg/500mg tablets should be administered with a meal.

How Biogliz M 2mg/500mg Tablet works:

Biogliz M, a 2mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Biogliz M 2mg/500mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Biogliz M 2mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice before use.

Breast feedingBreast feedingUNSAFE

Lactation and Biogliz M 2mg/500mg tablets are incompatible. Evidence indicates a potential for infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Biogliz M 2mg/500mg Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Biogliz M 2mg/500mg Tablets. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

For individuals with liver impairment, Biogliz M 2mg/500mg Tablets require careful administration. Dosage modifications may be necessary. Physician consultation is advised. In patients experiencing mild to moderate liver disease, a low initial dose of Biogliz M 2mg/500mg Tablets is typically prescribed; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Biogliz M 2mg/500mg Tablet :

Should you forget to take a Biogliz M 2mg/500mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.

Facts to Know About Biogliz M 2mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Biogliz M 2mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Biogliz M 2mg/500mg Tablets can cause lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis) resulting from excessive blood lactic acid. This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Biogliz M and seek immediate medical attention.
Biogliz M 2mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Biogliz M 2mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Biogliz M 2mg/500mg tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some research.
Biogliz M 2mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Biogliz M 2mg/500mg tablets with alcohol is unsafe. Alcohol can exacerbate the drug's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Biogliz M 2mg/500mg Table...
48
MRP 55
12% off